Improving cancer treatment through clinician scientist leadership in clinical trials
Official title: NCI R50 Clinician Scientist Award
Funded at University of California at Davis · NIH-11052542 · Data updated 2026-11-12
This study is all about helping doctors who specialize in cancer, like Dr. Brian Jonas, to run important tests on new treatments for leukemia and similar conditions, so that patients can get access to the latest and most effective therapies faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $87,347 |
| NIH project number | 5R50CA276013-03 |
| Project ID | NIH-11052542 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with acute leukemia or related hematologic malignancies who are seeking innovative treatment options.
✕Less likely to help
Patients with non-hematologic cancers or those not diagnosed with acute leukemia may not benefit from this research.
What this research studies
This research focuses on enhancing cancer care by empowering clinician scientists to lead and manage clinical trials for novel cancer treatments. By providing dedicated time and resources, the project aims to facilitate the development and implementation of national clinical trials, particularly for acute leukemia and related conditions. The principal investigator, Dr. Brian Jonas, is a leukemia specialist who will oversee these efforts at UC Davis, ensuring that innovative therapies are tested and made available to patients. The approach emphasizes collaboration within the NCI clinical trials networks to expedite the discovery of effective cancer therapies.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for acute leukemia, improving patient outcomes.
How similar studies have gone: Previous research has shown success in enhancing cancer treatment outcomes through clinician-led clinical trials, indicating a promising approach.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Jonas, Brian a. — University of California at Davis
- Study coordinator: Jonas, Brian a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.